{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:19:05Z","timestamp":1791811145996,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jmig.2017.10.024","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T18:02:00Z","timestamp":1510596120000},"page":"644-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience"],"prefix":"10.1016","volume":"25","author":[{"given":"Valerio","family":"Gallotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Nero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2424-2691","authenticated-orcid":false,"given":"Giuseppe","family":"Vizzielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Gueli Alletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lodoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino Maria","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2017.10.024_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmig.2017.10.024_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ygyno.2016.04.537","article-title":"Surgical management of recurrent ovarian cancer","volume":"142","author":"Suh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/annonc\/mdw663","article-title":"Fifth ovarian cancer consensus conference of the gynecologic cancer InterGroup: recurrent disease","volume":"28","author":"Wilson","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0025","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Pujade-Lauraine","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(17)30279-6","article-title":"Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology\/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Coleman","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0035","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery in ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0045","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/bjc.2011.328","article-title":"Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort","volume":"105","author":"Zang","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmig.2017.10.024_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2013.06.020","article-title":"Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors","volume":"131","author":"Petrillo","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.jmig.2017.10.024_bib0055","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jmig.2017.10.024_bib0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdn591","article-title":"The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer","volume":"20","author":"Oksefjell","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","article-title":"A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection","volume":"19","author":"Tian","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2015.02.004","article-title":"External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer","volume":"137","author":"van de Laar","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0075","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2017.10.024_bib0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.21652","article-title":"Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients","volume":"102","author":"Sehouli","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2407-14-22","article-title":"Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study","volume":"14","author":"van de Laar","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmig.2017.10.024_bib0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000841","article-title":"Correspondence: premature stop of the SOCceR trial, a multicenter randomized controlled trial on secondary cytoreductive surgery: Netherlands Trial Register number: NTR3337","volume":"27","author":"van de Laar","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl","key":"10.1016\/j.jmig.2017.10.024_bib0100","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1200\/JCO.2017.35.15_suppl.5501","article-title":"Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20","volume":"35","author":"Du Bois","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0105","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ajog.2004.02.034","article-title":"Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking","volume":"190","author":"Trinh","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4293\/108680812X13462882736691","article-title":"Safety and efficacy of video laparoscopic surgical debulking of recurrent ovarian, fallopian tube, and primary peritoneal cancers","volume":"16","author":"Nezhat","year":"2012","journal-title":"JSLS"},{"key":"10.1016\/j.jmig.2017.10.024_bib0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2013.01.015","article-title":"Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy","volume":"129","author":"Magrina","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0120","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00464-013-3390-9","article-title":"Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience","volume":"28","author":"Gallotta","year":"2014","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jmig.2017.10.024_bib0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2014.05.007","article-title":"Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: a multi-institutional study","volume":"134","author":"Escobar","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2017.05.022","article-title":"Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: perioperative and oncologic outcomes","volume":"146","author":"Eriksson","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jmig.2014.11.008","article-title":"Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes","volume":"22","author":"Fagotti","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2013.12.028","article-title":"Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series","volume":"132","author":"Fagotti","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmig.2016.01.001","article-title":"Laparoscopic splenectomy for secondary cytoreduction in ovarian cancer patients with localized spleen recurrence: feasibility and technique","volume":"23","author":"Gallotta","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0150","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1245\/s10434-014-4141-4","article-title":"Development and assessment of Memorial Sloan Kettering Cancer Center's Surgical Secondary Events grading system","volume":"22","author":"Strong","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2014.09.006","article-title":"Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series","volume":"135","author":"Gallotta","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2017.10.024_bib0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000159266","article-title":"A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET\/CT and staging laparoscopy","volume":"75","author":"Fagotti","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.jmig.2017.10.024_bib0165","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jmig.2013.04.027","article-title":"Role of minimally invasive surgery in ovarian cancer","volume":"20","author":"Nezhat","year":"2013","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465017312608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465017312608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T19:32:31Z","timestamp":1603308751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465017312608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1553465017312608"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2017.10.024","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2017.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AAGL. All rights reserved.","name":"copyright","label":"Copyright"}]}}